| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10594579 | Bioorganic & Medicinal Chemistry Letters | 2012 | 5 Pages |
Abstract
CX4945, a potent and selective small molecule inhibitor of CK2, exhibits its anti-cancer activity in LNCap cells via the independent inhibitions of AR and Akt-survivin signalings.
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Byung Jun Ryu, Seung-hwa Baek, Jiyeon Kim, Su Jung Bae, Sung-Youn Chang, Jung-Nyoung Heo, Hyuk Lee, Sang Yeol Lee, Seong Hwan Kim,